Gorman-Rupp Reports First Quarter 2025 Financial Results
First Quarter 2025 Highlights
-
Net sales of
$163.9 million increased 2.9%, or$4.7 million , compared to the first quarter of 2024 -
First quarter net income was
$12.1 million , or$0.46 per share, compared to net income of$7.9 million , or$0.30 per share, for the first quarter of 2024 -
Adjusted EBITDA1 of
$29.7 million for the first quarter of 2025 increased$1.5 million , or 5.3%, from$28.2 million for the first quarter of 2024 -
Total debt decreased
$14.6 million during the quarter
Net sales for the first quarter of 2025 were
Sales increased
Gross profit was
Selling, general and administrative (“SG&A”) expenses were
Operating income was
Interest expense was
Net income was
Adjusted EBITDA1 was
The Company’s backlog of orders was
Net cash provided by operating activities for the first three months of 2025 was
About
Founded in 1933,
(1) Non-GAAP Information
This release includes certain non-GAAP financial data and measures such as adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”). Adjusted earnings before interest, taxes, depreciation and amortization is net income (loss) excluding interest, taxes, depreciation and amortization, adjusted to exclude non-cash LIFO2 expense. Management utilizes these adjusted financial data and measures to assess comparative operations against those of prior periods without the distortion of non-comparable factors. The inclusion of these adjusted measures should not be construed as an indication that the Company’s future results will be unaffected by unusual or infrequent items or that the items for which the Company has made adjustments are unusual or infrequent or will not recur. Further, the impact of the LIFO2 inventory costing method can cause results to vary substantially from company to company depending upon whether they elect to utilize LIFO2 and depending upon which method they may elect.
(2) LIFO Inventory Method
The majority of the Company’s inventories are valued on the last-in, first-out (LIFO) method and stated at the lower of cost or market. Current cost approximates replacement cost, or market, and LIFO cost is determined at the end of each fiscal year based on inventory levels on-hand at current replacement cost and a LIFO reserve. The Company uses the simplified LIFO method, under which the LIFO reserve is determined utilizing the inflation factor specified in the Producer Price Index for
Forward-Looking Statements
In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995,
|
|||||||
Condensed Consolidated Statements of Income (Unaudited) |
|||||||
|
Three Months Ended
|
|
|||||
(Dollars in thousands, except per share amounts) |
2025 |
|
|
2024 |
|
||
Net sales |
$ |
163,948 |
|
|
$ |
159,268 |
|
Cost of products sold |
|
113,616 |
|
|
|
110,874 |
|
Gross profit |
|
50,332 |
|
|
|
48,394 |
|
Selling, general and administrative expenses |
|
25,107 |
|
|
|
24,888 |
|
Amortization expense |
|
3,100 |
|
|
|
3,077 |
|
Operating income |
|
22,125 |
|
|
|
20,429 |
|
Interest expense |
|
(6,203 |
) |
|
|
(10,073 |
) |
Other income (expense), net |
|
(386 |
) |
|
|
(272 |
) |
Income before income taxes |
|
15,536 |
|
|
|
10,084 |
|
Provision for income taxes |
|
3,408 |
|
|
|
2,200 |
|
Net income |
$ |
12,128 |
|
|
$ |
7,884 |
|
Earnings per share |
$ |
0.46 |
|
|
$ |
0.30 |
|
Average number of shares outstanding |
|
26,246,848 |
|
|
|
26,201,093 |
|
|
||||||||
Condensed Consolidated Balance Sheets (Unaudited) |
||||||||
|
|
(unaudited) |
|
|
|
|
||
(Dollars in thousands) |
|
|
|
|
|
|
||
Assets |
|
|||||||
Cash and cash equivalents |
|
$ |
21,840 |
|
|
$ |
24,213 |
|
Accounts receivable, net |
|
|
93,531 |
|
|
|
87,636 |
|
Inventories, net |
|
|
99,152 |
|
|
|
99,205 |
|
Prepaid and other |
|
|
9,747 |
|
|
|
9,773 |
|
Total current assets |
|
|
224,270 |
|
|
|
220,827 |
|
Property, plant, and equipment |
|
|
131,506 |
|
|
|
131,822 |
|
Other assets |
|
|
23,069 |
|
|
|
23,838 |
|
|
|
|
479,002 |
|
|
|
481,982 |
|
Total assets |
|
$ |
857,847 |
|
|
$ |
858,469 |
|
Liabilities and equity |
|
|||||||
Accounts payable |
|
$ |
27,403 |
|
|
$ |
24,752 |
|
Current portion of long-term debt |
|
|
18,500 |
|
|
|
18,500 |
|
Accrued liabilities and expenses |
|
|
46,781 |
|
|
|
44,275 |
|
Total current liabilities |
|
|
92,684 |
|
|
|
87,527 |
|
Pension benefits |
|
|
6,459 |
|
|
|
6,629 |
|
Postretirement benefits |
|
|
22,216 |
|
|
|
22,178 |
|
Long-term debt, net of current portion |
|
|
333,706 |
|
|
|
348,097 |
|
Other long-term liabilities |
|
|
20,711 |
|
|
|
20,238 |
|
Total liabilities |
|
|
475,776 |
|
|
|
484,669 |
|
Shareholders' equity |
|
|
382,071 |
|
|
|
373,800 |
|
Total liabilities and shareholders' equity |
|
$ |
857,847 |
|
|
$ |
858,469 |
|
|
|||||||
Condensed Consolidated Statements of Cash Flows (Unaudited) |
|||||||
|
Three Months Ended
|
|
|||||
(Dollars in thousands) |
2025 |
|
|
2024 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
||
Net income |
$ |
12,128 |
|
|
$ |
7,884 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
||
Depreciation and amortization |
|
6,963 |
|
|
|
7,065 |
|
LIFO expense |
|
995 |
|
|
|
993 |
|
Pension expense |
|
696 |
|
|
|
663 |
|
Stock based compensation |
|
1,048 |
|
|
|
1,074 |
|
Amortization of debt issuance fees |
|
295 |
|
|
|
767 |
|
Other |
|
(489 |
) |
|
|
97 |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
||
Accounts receivable, net |
|
(5,359 |
) |
|
|
(5,425 |
) |
Inventories, net |
|
(231 |
) |
|
|
1,462 |
|
Accounts payable |
|
2,408 |
|
|
|
4,624 |
|
Commissions payable |
|
2,471 |
|
|
|
(1,826 |
) |
Deferred revenue and customer deposits |
|
(1,548 |
) |
|
|
(169 |
) |
Income taxes |
|
2,608 |
|
|
|
2,406 |
|
Accrued expenses and other |
|
589 |
|
|
|
(4,120 |
) |
Benefit obligations |
|
(1,474 |
) |
|
|
(4,753 |
) |
Net cash provided by operating activities |
|
21,100 |
|
|
|
10,742 |
|
Cash flows from investing activities: |
|
|
|
|
|
||
Capital additions |
|
(3,020 |
) |
|
|
(3,906 |
) |
Other |
|
19 |
|
|
|
52 |
|
Net cash used for investing activities |
|
(3,001 |
) |
|
|
(3,854 |
) |
Cash flows from financing activities: |
|
|
|
|
|
||
Cash dividends |
|
(4,852 |
) |
|
|
(4,715 |
) |
|
|
(1,141 |
) |
|
|
(267 |
) |
Payments to banks for borrowings |
|
(14,625 |
) |
|
|
(4,375 |
) |
Other |
|
(30 |
) |
|
|
(17 |
) |
Net cash used for financing activities |
|
(20,648 |
) |
|
|
(9,374 |
) |
Effect of exchange rate changes on cash |
|
176 |
|
|
|
(260 |
) |
Net increase (decrease) in cash and cash equivalents |
|
(2,373 |
) |
|
|
(2,746 |
) |
Cash and cash equivalents: |
|
|
|
|
|
||
Beginning of period |
|
24,213 |
|
|
|
30,518 |
|
End of period |
$ |
21,840 |
|
|
$ |
27,772 |
|
|
|||||||||
Non-GAAP Financial Information |
|||||||||
(thousands of dollars, except per share data) |
|||||||||
|
|
Three Months Ended
|
|
|
|||||
|
|
2025 |
|
|
2024 |
|
|
||
Adjusted earnings before interest, taxes, depreciation and amortization: |
|
|
|
|
|
|
|
||
Reported net income –GAAP basis |
|
$ |
12,128 |
|
|
$ |
7,884 |
|
|
Interest expense |
|
|
6,203 |
|
|
|
10,073 |
|
|
Provision for income taxes |
|
|
3,408 |
|
|
|
2,200 |
|
|
Depreciation and amortization expense |
|
|
6,963 |
|
|
|
7,065 |
|
|
Non-GAAP earnings before interest, taxes, depreciation and amortization |
|
|
28,702 |
|
|
|
27,222 |
|
|
Non-cash LIFO expense |
|
|
995 |
|
|
|
993 |
|
|
Non-GAAP adjusted earnings before interest, taxes, depreciation and amortization |
|
$ |
29,697 |
|
|
$ |
28,215 |
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20250424898824/en/
Corporate Secretary
Telephone (419) 755-1246
NYSE: GRC
For additional information, contact
Source: